Atezolizumab (Mechanism of Action)

In this article we will discuss Atezolizumab (Mechanism of Action)

Cetuximab

In this article, we will discuss about Cetuximab (Indications). So, let's get started. Indications Cetuximab (ERBITUX®) is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer • Locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. • Recurrent locoregional disease or … Continue reading Cetuximab